Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

FDA Stops Imports of Ranbaxy Products
The U.S. Food and Drug Administration (FDA) is stopping the import of several drug products produced by the generic drug manufacturer Ranbaxy Laboratories, Ltd.  The FDA is concerned that Ranbaxy facilities in India are not following U.S. standards for good manufacturing practices.  Although loratadine is one of the medications manufactured by Ranbaxy, drug shortages are not expected because, in most instances, there are enough other suppliers that can help meet demand for loratadine. For more information, please visit: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116949.htm
Learn More

FDA Stops Imports of Ranbaxy Products
The U.S. Food and Drug Administration (FDA) is stopping the import of several drug products produced by the generic drug manufacturer Ranbaxy Laboratories, Ltd.  The FDA is concerned that Ranbaxy facilities in India are not following U.S. standards for good manufacturing practices.  Although metformin is one of the medications manufactured by Ranbaxy, drug shortages are not expected because, in most instances, there are enough other suppliers that can help meet demand for metformin. For more information, please visit: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116949.htm
Learn More

Date Published Title Drug Source
2008-09-18 FDA Stops Imports of Ranbaxy Products Loratadine FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Metformin FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Nefazodone FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Nitrofurantoin FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Ofloxacin FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Pravastatin FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Ranitidine FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Simvastatin FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Terazosin FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Valacyclovir FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Zidovudine FDA
2008-09-18 FDA Stops Imports of Ranbaxy Products Ganciclovir FDA
2008-09-18 Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures Esomeprazole MediGuard CRT
2008-09-18 Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures Lansoprazole MediGuard CRT
2008-09-18 Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures Omeprazole MediGuard CRT
2008-09-18 Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures Pantoprazole MediGuard CRT
2008-09-18 Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures Rabeprazole MediGuard CRT
2008-09-12 New Safety Information: Rituxan (Rituximab) and Progressive Multifocal Leukoencephalopathy (PML) Rituximab Manufacturer
2008-09-04 TNF Blockers Increase the Risk of Fungal Infections Etanercept FDA
2008-09-04 TNF Blockers Increase the Risk of Fungal Infections Certolizumab FDA
Back to Consumer Med Safety